Johnson & Johnson, founded in 1886, makes and sells medical devices, pharmaceuticals, and consumer health products. Headquartered in New Brunswick, N.J., the company operates over 250 subsidiary ...

Healthcare conglomerate Johnson & Johnson on Tuesday kicked off ... tens of thousands of women who claimed the company’s talc products contained asbestos and caused ovarian and other ...

(To receive weekly emails of conversations with the world’s top CEOs and decisionmakers, click here.) It’s nearly a year and a half since Johnson & Johnson split off its consumer-health arm to ...

In the latest trading session, Johnson & Johnson (JNJ ... The the stock of world's biggest maker of health care products has risen by 0.15% in the past month, leading the Medical sector's loss ...

For 2025, Johnson & Johnson projects its operational sales growth to be around 3%. But if the Intra-Cellular deal goes through and results in more products contributing to its top line ...

Johnson & Johnson has been a long-time partner of Save the Children. Our shared vision is a world where no child dies from preventable causes and every child has the opportunity to reach their full ...

New Brunswick, New Jersey-based Johnson & Johnson (JNJ) researches, develops, manufactures, and sells various products in the healthcare field. Valued at a market cap of $366.3 billion ...

Some might describe Johnson & Johnson's business as boring, but sometimes, that's not such a bad thing. Selling pharmaceutical products is a steady and reliable business even when the economy is ...

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other long term low risk stocks. As the DeepSeek craze ignites a sell-off in the tech sector ...

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and ...